The clinical efficacy of intratumoral OK-432 administration in advanced cancer patientsTetsuya Toge, Takao Hattori, Nobutoshi Baba et al.|Surgery Today|1988Cited by 6
Effects of the oral or intratumoral administration of OK432 on the immuno-reactivities of regional lymph nodes in gastric cancer patientsEtsuro Yanagawa, Yukio Sato, Tetsuya Toge et al.|Surgery Today|1991Cited by 2
Natural killer cell and suppressor cell activities of the spleen cells in cancer patientsEtsuro Yanagawa, Takao Hattori, Tetsuya Toge et al.|Japanese Journal of Clinical Immunology|1987Cited by 2